Analysis and intervention strategies for 528 cases of serious adverse events in tumor drug clinical trials based on ethical review
1.Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China
2.Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China
3.National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China
4.Hunan Provincial International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Products, Changsha 410008, Hunan Province, China
收起